EASY Algorithm Trial (Elbow Trauma Assessment Using Sonography in Children and Youth) Diagnostic Accuracy and Safety of Point-of-care Ultrasound as a Screening Tool for Suspected Elbow Fractures in Children Aged 5 to 15 Years: a Multicenter Prospective Cohort Study
EASY Algorithm
1 other identifier
observational
543
1 country
13
Brief Summary
The goal of this observational study is to learn about the safety and accuracy of ultrasound as a screening tool to detect broken bones (fractures) in the elbow area in children and youth aged 5 to 15 years. The main question it aims to answer is: \- Can ultrasound reliably show that there is a fracture in the elbow area after an accident? Participants will:
- Have an ultrasound of their elbow to look for fluid in the joint.
- Have standard X-rays of their elbow to check if there is a fracture.
- Have their medical records checked and answer a phone call 6 weeks later to see how their elbow has healed (only if no fracture was found during the first visit).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2026
Shorter than P25 for all trials
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2026
CompletedFirst Posted
Study publicly available on registry
February 24, 2026
CompletedStudy Start
First participant enrolled
March 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 15, 2027
April 8, 2026
April 1, 2026
8 months
February 15, 2026
April 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity of sonographic joint effusion
Sensitivity of sonographic joint effusion examination following a standardized procedure and uniform training of the physicians performing the examination in the detection of radiologically confirmed elbow fractures, as assessed by blinded experts.
Day 1 (On the day of enrollment in the study in the emergency department)
Secondary Outcomes (11)
Time required for ultrasound examination
Day 1 (On the day of enrollment in the study in the emergency department)
The additional time patients spend in the emergency room due to X-ray examinations
Day 1 (On the day of enrollment in the study in the emergency department)
Radiation dose from X-ray imaging (dose area product)
Day 1 (On the day of enrollment in the study in the emergency department)
The initial assessment of the X-ray images by the attending physician in the emergency department
Day 1 (On the day of enrollment in the study in the emergency department)
Treatment of the injury
Day 1 (On the day of enrollment in the study in the emergency department)
- +6 more secondary outcomes
Other Outcomes (1)
Potential confounders of the primary outcome
Day 1 (On the day of enrollment in the study in the emergency department)
Eligibility Criteria
All children and adolescents who present to the emergency departments of the participating hospitals with elbow pain following an accident will be screened for inclusion in the study during the study period until the statistically determined required number of cases has been reached.
You may not qualify if:
- elbow trauma as part of a polytrauma,
- parents' insufficient German language skills (spoken or written),
- trauma more than 72 hours ago,
- presentation at the emergency room with current, post-traumatic external X-ray images of the affected elbow joint from another clinic or practice,
- open fracture of the affected elbow joint,
- skin avulsion of the affected elbow joint,
- visible deformity of the affected elbow joint,
- and pathological status of peripheral circulation, motor function, and/or sensitivity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Tuebingencollaborator
- Timo Munzlead
- University Hospital Dresdencollaborator
- Helios Klinikum Berlin-Buchcollaborator
- Abteilung für Orthopädie und Unfallchirurgie BG Unfallklinik Duisburgcollaborator
- University Hospital Freiburgcollaborator
- Universitätsklinikum Hamburg-Eppendorfcollaborator
- Klinikum Kasselcollaborator
- Vivantes Hospital Berlin Neuköllncollaborator
- Klinikum Stuttgartcollaborator
- Klinikum Chemnitz gGmbHcollaborator
- University Hospital Lübeckcollaborator
Study Sites (13)
Klinikum St. Marien Amberg
Amberg, 92224, Germany
Vivantes Klinikum Neukölln
Berlin, 12351, Germany
Helios Klinikum Berlin-Buch
Berlin, 13125, Germany
Charité - Universitätsmedizin Berlin
Berlin, 13353, Germany
Klinikum Chemnitz
Chemnitz, 09116, Germany
Universitätsklinikum Carl Gustav Carus Dresden
Dresden, 01307, Germany
BG Klinikum Duisburg
Duisburg, 47249, Germany
Universitätsklinikum Freiburg
Freiburg im Breisgau, 79106, Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, 20251, Germany
Klinikum Kassel
Kassel, 34125, Germany
Universitätsklinikum Schleswig-Holstein Campus Lübeck
Lübeck, 23562, Germany
Klinikum Stuttgart
Stuttgart, 70174, Germany
Universitätsklinikum Tübingen
Tübingen, 72076, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr. med. Timo Munz, Principal Investigator
Study Record Dates
First Submitted
February 15, 2026
First Posted
February 24, 2026
Study Start
March 2, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
January 15, 2027
Last Updated
April 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Individual participant data will be made available beginning 6 months following the publication of the primary manuscript in a peer-reviewed journal. To ensure long-term reproducibility and transparency, the data will be hosted in a permanent data repository \[e.g., Zenodo\] with no set expiration date.
- Access Criteria
- De-identified individual participant data and supporting documents (Protocol, SAP, Analytic Code) will be made available to qualified researchers for legitimate scientific purposes. Access will be managed through a restricted-access data repository \[e.g., Zenodo\]. To obtain access, researchers must submit a formal request through the repository's 'Request Access' feature, including a brief research proposal and a statistical analysis plan. Requests will be reviewed by the study investigators to ensure scientific merit and ethical compliance. Upon approval, and following the signing of a Data Access Agreement to protect participant confidentiality, the data will be released directly through the repository platform.
All IPD collected throughout the trial.